跳至主要内容
临床试验/NCT02991170
NCT02991170Unknown不适用

Impact of Radiofrequency Ablation Therapy in Coronary Artery Bypass Grafts Surgery on Outcomes in Patients With Myocardial Infarction Related Ventricular Arrhythmia

Beijing Anzhen Hospital3 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2015年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
180
试验地点
3
主要终点
Morbidity of potential malignant ventricular arrhythmia

研究概览

简要总结

Patients with myocardial infarction related potential malignant ventricular arrhythmia have high risk of sudden death. The aim of this clinical trial is evaluating therapeutic efficacy of unipolar or bipolar radiofrequency ablation in Coronary Artery Bypass Grafts (CABG) Surgery, which can reduce myocardial ischemia and block reentry circuits of ventricular arrhythmia at the same time. The observation indexes include the morbidity of potential malignant ventricular arrhythmia and major adverse cardiovascular events in mid-long-term after CABG surgery.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patients have been receiving coronary artery bypass grafts from 2015.1-2017.12
  • The patients had old myocardial infarction related potential malignant ventricular arrhythmia
  • Anti-arrhythmic drug treatment is invalid
  • All enrolled patients must being signed the informed consent

排除标准

  • Severe heart failure( ejection fraction under 35%)
  • Patients with acute myocardial infarction
  • Patients with ICD implanted

结局指标

主要结局

Morbidity of potential malignant ventricular arrhythmia

时间窗: 1 year after surgery

The morbidity of potential malignant ventricular arrhythmia in 1 year after surgery

次要结局

  • Morbidity of major adverse cardiovascular events(1 year after surgery)

研究者

发起方
Beijing Anzhen Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Yu

Deputy Director of Cardiac Surgery, Principal Investigator,Clinical Professor

Beijing Anzhen Hospital

研究点 (3)

Loading locations...

相似试验